Angewandte
Chemie
DOI: 10.1002/anie.201410309
Macrocyclic Sulfates
Highly Efficient Synthesis of Monodisperse Poly(ethylene glycols) and
Derivatives through Macrocyclization of Oligo(ethylene glycols)**
Hua Zhang, Xuefei Li, Qiuyan Shi, Yu Li, Guiquan Xia, Long Chen, Zhigang Yang, and Zhong-
Xing Jiang*
Abstract: A macrocyclic sulfate (MCS)-based approach to
monodisperse poly(ethylene glycols) (M-PEGs) and their
monofunctionalized derivatives has been developed. Macro-
cyclization of oligo(ethylene glycols) (OEGs) provides MCS
(up to a 62-membered macrocycle) as versatile precursors for
a range of monofunctionalized M-PEGs. Through iterative
nucleophilic ring-opening reactions of MCS without perform-
ing group protection and activation, a series of M-PEGs,
including the unprecedented 64-mer (2850 Da), can be readily
prepared. Synthetic simplicity coupled with versatility of this
new strategy may pave the way for broader applications of M-
PEGs.
P
EGs are biocompatible polymers with diverse applications.
Regular PEGs even with an excellent polydispersity index
(PDI) are still complex mixtures of different length oligo-
mers[1] (Figure 3, PEG1500), which brings a range of prob-
lems in their applications.[2] Therefore, M-PEGs are much
more desirable than regular PEGs.[3] However, efficient
synthesis of M-PEGs remains a long-standing challenge
even after decades of efforts[1,4] owing to the following
issues (Scheme 1, chain tripling method was illustrated as an
example): 1) Long synthesis, low yield, and tedious purifica-
tion dramatically deteriorate the synthetic efficacy. 2) No
synthesis on M-PEGs above 2500 Da has ever been reported.
The longest M-PEGs reported so far is a 56-mer (2484 Da)
which was recently synthesized by Livingstonꢀs group.[4j] It is
noteworthy that 4000 Da is regarded as a minimum require-
ment for PEGs to achieve the so-called stealth effect in
biopharmaceuticals.[5] 3) PEG monofunctionalization is a dif-
ficult task because it requires large excess amount of PEGs
(up to 10 equiv), expensive reagents, and tedious manipula-
tion of protecting and activating group(s).[4g,6] Therefore, new
synthetic strategies to address these issues are of great
importance.
Scheme 1. Strategies for M-PEGs and synthesis of derivatives.
Transforming 1,2- or 1,3-diols into the corresponding
cyclic sulfates, where the sulfate group acts as both a protect-
ing group and an activating group during nucleophilic ring-
opening reaction, has been widely used in the monofunction-
alization of these diols.[7,8] We envisioned that this strategy
could be applied in the synthesis of M-PEGs and derivatives
to improve the synthetic efficacy by avoiding hydroxy group
protection and activation as well as undesired difunctional-
ization (Scheme 1).
To our knowledge, there is no report on MCS, but three
reports of formation of macrocyclic sulfites (17-membered
and below).[9] After unsuccessful attempts on the macro-
cyclization of commercially available tetra(ethylene glycol)
1a through transesterification[10] with diisopropyl sulfite,
macrocyclization of 1a with SOCl2 in the presence of Et3N
was carried out (Supporting Information, Table S1). Fortu-
nately, the 14-membered macrocyclic sulfite 3a was obtained
in a 51% yield (Table S1, entry 1). It was found that excess
amount of reagents is required to promote the reaction
(Table S1, entries 2–5). Elevated temperature and high con-
centration of 1a both lowered the yield of 3a (Table S1,
entries 4,6,7) while the latter is a common phenomenon in
macrocyclization. It was also found that slow addition of
SOCl2 over 1 hour and stirring at 08C for an additional hour
provided a high yield of 3a (Table S1, entries 8–10). Monitor-
ing the reaction with 1H NMR indicated that slow addition of
SOCl2 is crucial for the macrocyclization process (Supporting
Information, Figure S1). As for the base, DIPEA, DMAP or
their combination gave much better yields of 3a than K2CO3
or pyridine (Table S1, entries 11–14). Solvent screening
[*] H. Zhang,[+] X. Li,[+] Q. Shi, Y. Li, G. Xia, L. Chen, Prof. Z. Yang,
Prof. Z.-X. Jiang
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery
(Wuhan University), Ministry of Education, and Wuhan University
School of Pharmaceutical Sciences
Wuhan 430071 (China)
E-mail: zxjiang@whu.edu.cn
[+] These authors contributed equally to this work.
[**] The research was financially supported by the National Natural
Science Foundation of China (No. 21372181). We thank Dr. Yihua
Bruce Yu, Dr. Wei Zhang, Dr. Xingang Zhang, and Dr. Xiuhua Xu for
their help with the manuscript preparation.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2015, 54, 1 – 6
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1
These are not the final page numbers!